We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ISTR:NASDAQInvestar Holding Corporation Analysis

Data as of 2026-06-12 - not real-time

$29.78

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Investar Holding is trading at $29.78, comfortably above its 20‑day SMA of $28.52 and the 50‑day SMA, confirming a bullish price bias. Technical momentum is reinforced by a bullish MACD crossover and a RSI of 67, suggesting the stock is approaching overbought territory but still has room to run. The 30‑day volatility of roughly 18½% and a beta of 0.82 indicate moderate price swings with less market‑wide risk than the broader index. Fundamentally, the company posted a striking 57.6% revenue surge and maintains a 44% operating margin, delivering a solid 26.7% profit margin. At a trailing P/E of 13.1 versus the industry average of 16.6, and a forward P/E near 9.1, the valuation appears attractive, especially given the DCF‑derived fair value of $34.4, implying roughly 11% upside. The dividend yield of 1.48% with a modest 19% payout ratio underscores sustainability, while recent shareholder approval of the director slate and incentive plan adds governance confidence.
The balance sheet shows cash of $90.9 M against debt of $209 M, and the firm’s market cap of $410 M provides sufficient liquidity, though trading volumes are modestly improving. With a strong earnings outlook, a dividend that can be comfortably covered, and a valuation gap to intrinsic value, the stock is positioned for medium‑ to long‑term appreciation, while short‑term traders should watch the nearby resistance at $29.88 and the elevated RSI for potential profit‑taking pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance level of $29.88
  • Elevated RSI indicating potential short‑term pullback
  • Bullish MACD confirming underlying momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF fair value and industry P/E
  • Robust revenue growth and high operating margins
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistent earnings expansion and strong cash generation
  • Low beta and moderate volatility supporting defensive profile
  • Positive governance outcomes and dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth57.60%
Profit Margin26.73%
P/E Ratio13.1
ROE8.59%
ROA0.87%
P/B Ratio1.1
Op. Cash Flow$23.7M
Industry P/E16.6

Technical Analysis

TrendBullish
RSI67.3
Support$27.52
Resistance$29.88
MA 20$28.52
MA 50$28.29
MA 200$26.36
MACDBullish
VolumeIncreasing
Fear & Greed Index88.2

Valuation

Fair Value$34.37
Target Price$33.00
Upside/Downside10.81%
GradeUndervalued
TypeBlend
Dividend Yield1.48%

Risk Assessment

Beta0.82
Volatility18.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.